FCUV experienced severe operational deterioration with gross profit swinging from $10K to -$35K loss while net losses increased 50% to $4.8M despite significantly strengthened balance sheet from apparent capital raising.
The company is burning through cash with worsening operational metrics - revenue declined 36% while costs exceeded revenues, creating negative gross margins. However, the doubling of total assets to $8.9M and major debt reduction suggests recent equity financing that provides near-term liquidity but at likely significant dilution to existing shareholders.
FCUV shows a tale of two stories - dramatically improved balance sheet strength with current assets more than doubling to $8.6M and total liabilities cut by 59%, likely from equity capital raising, but severely deteriorating operations with revenue falling 36% to $255K and the company posting negative gross margins. The 50% increase in net losses to $4.8M combined with the balance sheet improvement suggests the company raised significant capital but is burning through it rapidly with poor operational execution, creating a race between funding runway and achieving profitability.
Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.
Current assets grew 124.8% — improving short-term liquidity or inventory/receivables build.
Asset base grew 117.8% — expansion through organic growth, acquisitions, or capital deployment.
Interest expense declined — debt repayment or refinancing at lower rates improving earnings quality.
Liabilities reduced 58.6% — deleveraging improves balance sheet strength and financial flexibility.
Current liabilities reduced — improved short-term financial position and working capital health.
Capital expenditure jumped 50.4% — major investment cycle underway; assess returns on deployment.
Net income declined 49.6% — review whether driven by operations, interest costs, or non-recurring items.
Revenue declined 35.9% — significant demand weakness or market share loss warrants investigation.
R&D spending cut 33.4% — could signal cost discipline or concerning reduction in innovation investment.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →